(Q66974310)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:513483%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

title

Vaule of renin measurement, saralasin test, and acebutolol treatment in hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:513483%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

Value of renin measurement, saralasin test, and acebutolol treatment in hypertension (English)

1 reference

18 June 2023

1 reference

18 June 2023

author name string

C. Kreft

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A513483

18 June 2023

J. Menard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A513483

18 June 2023

P. Corvol

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A513483

18 June 2023

language of work or name

English

0 references

publication date

1 February 1979

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:513483%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

1 September 2019

https://api.elsevier.com/content/article/PII:S0085253815320378?httpAccept=text/xml

1 reference

https://api.elsevier.com/content/article/PII:S0085253815320378?httpAccept=text/plain

18 June 2023

1 reference

18 June 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:513483%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:513483%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:513483%20AND%20SRC:MED&resulttype=core&format=json

1 September 2019

page(s)

176-183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:513483%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.1979.23

1 September 2019

exact match

0 references

cites work

Modern system for treating high blood pressure based on renin profiling and vasoconstriction-volume analysis: A primary role for beta blocking drugs such as propranolol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Hypotensive action of propranolol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Angiotensin blockade: its clinical significance

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Use of an Angiotensin II Antagonist (Saralasin) in the Recognition of “Angiotensinogenic” Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Rapid identification of patients with essential hypertension sensitive to acebutolol (a new cardioselective beta-blocker)

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

A direct determination of plasma aldosterone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Infusion of angiotensin-II analogue in two patients with unilateral renovascular hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Methodologic problems in plasma renin activity measurements

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Improved assay methods for renin "concentration" and "activity" in human plasma. Methods using selective denaturation of renin substrate

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Circulating renin in essential hypertension: an evaluation of its significance in the Japanese population

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Saralasin infusion in the recognition of renovascular hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Angiotensin Blockade in Renovascular Hypertension: A Controlled, Prospective Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over saralasin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Reciprocal relation between renin dependency and sodium dependency in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Renin dependency of blood-pressure. Analysis by angiotensin II antagonist P113 in hypertensive patients treated with salt depletion and propranolol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Non-renin-mediated renovascular hypertension: A new syndrome?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Activity of various fractions of bradykinin potentiating factor against angiotensin I converting enzyme

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Inhibition of Human Plasma Renin Activity by Pepstatin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.23

7 January 2021

Failure of saralasin to predict a response to surgery in renovascular hypertension

31

1 reference